Andra AP-fonden’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-129,385
Closed -$10.2M 408
2025
Q4
$10.2M Sell
129,385
-108,200
-46% -$8.48M 0.13% 207
2025
Q3
$19M Sell
237,585
-13,800
-5% -$1.18M 0.24% 142
2025
Q2
$22.9M Buy
251,385
+4,400
+2% +$402K 0.32% 113
2025
Q1
$23.1M Sell
246,985
-109,700
-31% -$9.82M 0.38% 87
2024
Q4
$32.4M Sell
356,685
-127,700
-26% -$12.2M 0.52% 39
2024
Q3
$50.3M Buy
484,385
+63,300
+15% +$6.45M 0.74% 17
2024
Q2
$40.9M Buy
421,085
+71,100
+20% +$6.56M 0.69% 22
2024
Q1
$31.5M Buy
+349,985
New +$29.7M 0.56% 41
2023
Q3
Sell
-66,385
Closed -$5.11M 323
2023
Q2
$5.11M Sell
66,385
-8,600
-11% -$666K 0.13% 376
2023
Q1
$5.64M Buy
74,985
+9,885
+15% +$735K 0.15% 305
2022
Q4
$5.13M Sell
65,100
-40,100
-38% -$3.01M 0.16% 303
2022
Q3
$7.39M Sell
105,200
-6,000
-5% -$470K 0.24% 146
2022
Q2
$8.91M Buy
+111,200
New +$8.7M 0.26% 111
2021
Q4
$11.4M Buy
134,000
+12,500
+10% +$976K 0.23% 167
2021
Q3
$9.18M Buy
121,500
+21,200
+21% +$1.68M 0.19% 234
2021
Q2
$8.16M Buy
100,300
+4,500
+5% +$368K 0.17% 290
2021
Q1
$7.55M Sell
95,800
-16,100
-14% -$1.26M 0.17% 290
2020
Q4
$9.57M Buy
111,900
+4,700
+4% +$389K 0.21% 168
2020
Q3
$8.27M Buy
107,200
+37,300
+53% +$2.84M 0.22% 122
2020
Q2
$5.12M Sell
69,900
-8,300
-11% -$590K 0.15% 349
2020
Q1
$5.19M Sell
78,200
-6,300
-7% -$444K 0.19% 156
2019
Q4
$5.82M Sell
84,500
-5,200
-6% -$355K 0.17% 279
2019
Q3
$6.59M Buy
89,700
+1,700
+2% +$123K 0.2% 171
2019
Q2
$6.31M Buy
88,000
+9,700
+12% +$689K 0.18% 218
2019
Q1
$5.37M Buy
+78,300
New +$5.06M 0.16% 326
2018
Q3
$5.94M Sell
88,700
-7,400
-8% -$493K 0.15% 311
2018
Q2
$6.23M Buy
96,100
+14,700
+18% +$962K 0.17% 273
2018
Q1
$5.83M Sell
81,400
-101,421
-55% -$7.3M 0.15% 336
2017
Q4
$13.8M Sell
182,821
-779
-0.4% -$56.9K 0.31% 81
2017
Q3
$13.4M Buy
183,600
+8,600
+5% +$620K 0.31% 86
2017
Q2
$13M Sell
175,000
-127,494
-42% -$9.47M 0.32% 84
2017
Q1
$22.1M Sell
302,494
-20,706
-6% -$1.45M 0.52% 23
2016
Q4
$21.1M Buy
323,200
+7,700
+2% +$528K 0.58% 22
2016
Q3
$23.4M Sell
315,500
-16,200
-5% -$1.2M 0.63% 19
2016
Q2
$24.3M Buy
331,700
+46,100
+16% +$3.28M 0.62% 20
2016
Q1
$20.2M Sell
285,600
-19,900
-7% -$1.32M 0.53% 32
2015
Q4
$20.4M Sell
305,500
-5,300
-2% -$353K 0.58% 33
2015
Q3
$19.7M Buy
310,800
+14,900
+5% +$973K 0.58% 28
2015
Q2
$19.4M Sell
295,900
-8,400
-3% -$570K 0.56% 31
2015
Q1
$21.1M Sell
304,300
-60,300
-17% -$4.17M 0.6% 29
2014
Q4
$25.2M Buy
364,600
+5,700
+2% +$385K 0.58% 32
2014
Q3
$23.4M Buy
358,900
+21,600
+6% +$1.42M 0.55% 34
2014
Q2
$23M Buy
337,300
+240,400
+248% +$16.1M 0.5% 38
2014
Q1
$6.29M Sell
96,900
-86,500
-47% -$5.45M 0.15% 239
2013
Q4
$12M Sell
183,400
-8,400
-4% -$538K 0.28% 88
2013
Q3
$11.4M Sell
191,800
-45,800
-19% -$2.71M 0.29% 80
2013
Q2
$13.6M Buy
+237,600
New +$14.1M 0.35% 55

Other funds holding CL

Andra AP-fonden's CL Position: Q1 2026 in Review

Andra AP-fonden sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 129,385 shares — an estimated $10.2M sold.

Andra AP-fonden first reported a position in CL in Q2 2013 and held it in 47 quarters. The position peaked at $50.3M in Q3 2024. 1,959 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Andra AP-fonden reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Andra AP-fonden sold 129,385 Colgate-Palmolive shares in Q1 2026, an estimated $10.2M.
  • Andra AP-fonden first reported a position in Colgate-Palmolive in Q2 2013 and held it in 47 quarters.
  • Andra AP-fonden's Colgate-Palmolive position peaked at $50.3M in Q3 2024.
  • 1,959 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.